224 related articles for article (PubMed ID: 15877938)
1. Compliance and outcome of patients with stage 1 non-seminomatous germ cell tumors (NSGCT) managed with surveillance programs in seven Canadian centres.
Ernst DS; Brasher P; Venner PM; Czaykowski P; Moore MJ; Reyno L; Winquist E; Segal R; Hao D
Can J Urol; 2005 Apr; 12(2):2575-80. PubMed ID: 15877938
[TBL] [Abstract][Full Text] [Related]
2. Outcomes of surveillance protocol of clinical stage I nonseminomatous germ cell tumors-is shift to risk adapted policy justified?
Divrik RT; Akdoğan B; Ozen H; Zorlu F
J Urol; 2006 Oct; 176(4 Pt 1):1424-29; discussion 1429-30. PubMed ID: 16952649
[TBL] [Abstract][Full Text] [Related]
3. [Urologic treatment of testicular germ cell cancer].
Fernández Gómez JM; Escaf Barmadah S; Guate Ortiz JL; Martín Huescar A; Fresno Forcelledo F; García Rodríguez J; Rodríguez Faba O; Jalón Monzón A; Rodríguez Martínez JJ
Arch Esp Urol; 2002 Oct; 55(8):927-36. PubMed ID: 12455283
[TBL] [Abstract][Full Text] [Related]
4. Nonseminomatous germ cell testicular tumors clinical stage I: differentiated therapeutic approach in comparison with therapeutic approach using surveillance strategy only.
Ondrus D; Ondrusova M; Hornak M; Matoska J
Neoplasma; 2007; 54(5):437-42. PubMed ID: 17688374
[TBL] [Abstract][Full Text] [Related]
5. No role for routine chest radiography in stage I seminoma surveillance.
Tolan S; Vesprini D; Jewett MA; Warde PR; O'Malley M; Panzarella T; Sturgeon JF; Moore M; Tew-George B; Gospodarowicz MK; Chung PW
Eur Urol; 2010 Mar; 57(3):474-9. PubMed ID: 19577354
[TBL] [Abstract][Full Text] [Related]
6. Minimizing treatment without compromising cure with primary surveillance for clinical stage I embryonal predominant nonseminomatous testicular cancer: a population based analysis from British Columbia.
Al-Tourah AJ; Murray N; Coppin C; Kollmannsberger C; Man A; Chi KN
J Urol; 2005 Dec; 174(6):2209-13, discussion 2213. PubMed ID: 16280765
[TBL] [Abstract][Full Text] [Related]
7. Pattern of relapse after first line treatment of advanced stage germ-cell tumors.
Fléchon A; Culine S; Théodore C; Droz JP
Eur Urol; 2005 Dec; 48(6):957-63; discussion 963-4. PubMed ID: 16084010
[TBL] [Abstract][Full Text] [Related]
8. [Treatment of patients with stage I non-seminomatous testicular tumors with general orchiectomy].
Hornák M; Ondrus D
Z Urol Nephrol; 1988 Sep; 81(9):541-5. PubMed ID: 2853503
[TBL] [Abstract][Full Text] [Related]
9. Active surveillance after orchiectomy for nonseminomatous testicular germ cell tumors: late relapse may occur.
Boyer MJ; Cox K; Tattersall MH; Findlay MP; Grygiel J; Rogers J
Urology; 1997 Oct; 50(4):588-92. PubMed ID: 9338737
[TBL] [Abstract][Full Text] [Related]
10. Patients with non-seminoma germ cell tumours treated in a minor oncology department: the importance of multi-institutional protocols and research collaboration.
Kildahl-Andersen A; Erke MG; Sagstuen H; Bremnes RM
Acta Oncol; 2005; 44(6):537-44. PubMed ID: 16165912
[TBL] [Abstract][Full Text] [Related]
11. Surveillance in stage I testicular seminoma - risk of late relapse.
Chung P; Parker C; Panzarella T; Gospodarowicz MK; Jewett S; Milosevic MF; Catton CN; Bayley AJ; Tew-George B; Moore M; Sturgeon JF; Warde P
Can J Urol; 2002 Oct; 9(5):1637-40. PubMed ID: 12431325
[TBL] [Abstract][Full Text] [Related]
12. Surveillance following orchiectomy for stage I testicular seminoma: long-term outcome.
Yoshida T; Kakimoto K; Takezawa K; Arai Y; Ono Y; Meguro N; Kinouchi T; Nishimura K; Usami M
Int J Urol; 2009 Sep; 16(9):756-9. PubMed ID: 19659679
[TBL] [Abstract][Full Text] [Related]
13. Appropriateness of testicular cancer management: a population-based cohort study.
Cheung WY; Demers A; Hossain D; Owen T; Ahmed S; Czaykowski PM
Can J Urol; 2007 Jun; 14(3):3542-50. PubMed ID: 17594744
[TBL] [Abstract][Full Text] [Related]
14. Surgery in infants and children with testicular and paratesticular tumours: a single centre experience over a 25-year-period.
Tröbs RB; Krauss M; Geyer C; Tannapfel A; Körholz D; Hirsch W
Klin Padiatr; 2007; 219(3):146-51. PubMed ID: 17525908
[TBL] [Abstract][Full Text] [Related]
15. Retroperitoneal lymph node dissection for nonseminomatous germ cell testicular cancer: impact of patient selection factors on outcome.
Stephenson AJ; Bosl GJ; Motzer RJ; Kattan MW; Stasi J; Bajorin DF; Sheinfeld J
J Clin Oncol; 2005 Apr; 23(12):2781-8. PubMed ID: 15837993
[TBL] [Abstract][Full Text] [Related]
16. A surveillance study of clinical stage I nonseminomatous germ cell tumors of the testis: 10-year followup.
Nicolai N; Pizzocaro G
J Urol; 1995 Sep; 154(3):1045-9. PubMed ID: 7637051
[TBL] [Abstract][Full Text] [Related]
17. Prognostic factors for relapse in stage I testicular seminoma treated with surveillance.
Warde P; Gospodarowicz MK; Banerjee D; Panzarella T; Sugar L; Catton CN; Sturgeon JF; Moore M; Jewett MA
J Urol; 1997 May; 157(5):1705-9; discussion 1709-10. PubMed ID: 9112510
[TBL] [Abstract][Full Text] [Related]
18. Histological outcome of delayed orchidectomy after primary chemotherapy for metastatic germ cell tumour of the testis.
Ramani VA; Grey BR; Addla SK; Dunham MP; Sangar VK; Clarke NW
Clin Oncol (R Coll Radiol); 2008 Apr; 20(3):247-52. PubMed ID: 18093814
[TBL] [Abstract][Full Text] [Related]
19. Current management of stage I testicular non-seminomatous germ cell tumours.
Pectasides D; Pectasides E; Constantinidou A; Aravantinos G
Crit Rev Oncol Hematol; 2009 May; 70(2):114-23. PubMed ID: 18805019
[TBL] [Abstract][Full Text] [Related]
20. Progression detection of stage I nonseminomatous testis cancer on surveillance: implications for the followup protocol.
Sharir S; Jewett MA; Sturgeon JF; Moore M; Warde PR; Catton CN; Gospodarowicz MK
J Urol; 1999 Feb; 161(2):472-5; discussion 475-6. PubMed ID: 9915429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
